Abstract
Skin is the largest organ in the human body. Its surface ranges in average between 1.5 and 1.8 m2 and the thickness varies between 0.5 (lower eyelid) and 15 mm (foot sole) in a young healthy adult, resulting in a tissue volume of 7,500–27,000 mm3. The skin has to fulfill a magnitude of physiological organic tasks, which is indicated by the variety of tissue thicknesses. These tasks include mechanistic, metabolic, energetic and immunologic aspects. Skin was the first organ which had been tissue engineered in vitro and translated back into clinical application. Therefore it is a prime target for regenerative therapies, not only due to its easy accessibility but also, because of the fact that skin is one of the most active and continuously regenerating organs and therefore a fascinating model to learn more about the human body’s intrinsic regenerative mechanisms.
This book chapter focuses on the regenerative capacities of skin tissue and its comprising cell compartments and explains how the principles of skin regeneration may be translated into clinical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- TEN:
-
Toxic epidermal necrolysis
- EPO:
-
Erythropoietin
- EPOR2:
-
EPO Receptor 2
- EPOβ 1/2:
-
EPO Receptor β 1 or 2
- TNF-α:
-
Tumour Necrosis Factor α
- IL-2:
-
Interleukin 2
- IL-6:
-
Interleukin 6
- IL-8:
-
Interleukin 8
- TGFβ 1–3:
-
Transforming growth factor beta 1–3
- PDGF:
-
Platelet-derived growth factor
- PLC:
-
Phospholipase C
- PKB:
-
Proteinkinase B
- NFκB:
-
Nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells
- BAD:
-
Bcl-2-Antagonist of Cell Death
- GSK-3β:
-
Glycogen Synthase Kinase 3
- NO:
-
Nitric oxide
- Ca:
-
Calcium
References
Aasen T, Belmonte JC (2010) Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc 5(2):371–382. Epub 2010 Feb 4
Bader A, Machens HG (2010) Recombinant human EPO plays a pivotal role as a topical stem cell activator to reverse effects of damage to the skin in aging and trauma. Rejun Res 13:499
Bernaudin M et al (1999) A potential role for EPO in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643–651
Bodó E et al (2007) Human hair follicles are an extrarenal source and a nonhematopoietic target of EPO. FASEB 21:3346–3354
Bolognia JL et al (2007) Dermatology. Mosby, St. Louis. ISBN 1-4160-2999-0
Brines M et al (2004) EPO mediated tissue protection through an EPO and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 101:14907–14912
Brines M et al (2008) EPO-mediated tissue protection: reducing collateral damage from primary injury response. J Int Med 264:405–432
Buemi M et al (2004) Recombinant human EPO stimulates angiogenesis and healing of ischemic skin wounds. Shock 22:169–173
Burns T et al (2006) Rook’s textbook of dermatology CD-ROM. Wiley, Maiden. ISBN 1405131306
Converse JM et al (1975) Inosculation of vessels of skin graft and host bed: a fortuitous encounter. Br J Plast Surg 28:274–282
Egana JT et al (2009) The use of glandular-derived stem cells to improve vascularization in scaffold-mediated dermal regeneration. Biometerials 30:5918–5926
Ferguson MWJ et al (2004) Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Phil Trans R Soc Lond B 359:839–850
Fernandes KJ et al (2008) Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential. Philos Trans R Soc Lond B Biol Sci 363:185–198
Ferri C et al (2007) Treatment of severe scleroderma skin ulcers with recombinant human EPO. Clin Exp Dermatol 32:287–290
Freedberg IM et al (2003) Fitzpatrick’s dermatology in general medicine. McGraw-Hill, New York
Galeano M et al (2004) Recombinant human EPO stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 53:2509–2517
Galeano M et al (2006) Recombinant human EPO improves angiogenesis and wound healing in experimental burn wounds. Crit Care Med 34:1139–1146
Hollander DA (2004) Reconstruction of extensive soft tissue loss by transplantation of dermal and epidermal equivalents. Zentralbl Chir 129:29–36
Keast DH, Fraser C (2004) Treatment of chronic skin ulcers in individuals with anaemia of chronic disease using rhEPO: a review of four cases. Osteotomy Wound Manage 50:64–70
Lorenz K et al (2008) Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol 17:925–932
Lotze MT et al (2007) The great full death: damage-associated molecular pattern molecules and reduction/oxidation regulated immunity. Immunol Rev 220:60–81
McGrath JA et al (1971) Embryology of human skin. A review of ultrastructural studies. The Herman Beerman lecture. J Invest Dermatol 57:133–143
Meenakshi J et al (2005) Keloids and hyperthropic scars: a review. Indian J Plast Surg 38:175–179
Occleston NL et al (2008) Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 19(8):1047–1063
Peterson TE et al (2007) EPO tecting the endothelium. Br J Pharmacol 150:823–825
Petschnik AE et al (2009) Phenotypic indications that human sweat glands are a rich source of nestin-positive stem cell populations. Br J Dermatol 162(2):380–383
Racila D, Bickenbach JR (2009) Are epidermal stem cells unique with respect to aging? Aging 1(8):746–750
Rapini RP (2005) Practical dermatopathology. Elsevier/Mosby, Philadelphia. ISBN 0-323-01198-5
Rezaeian F et al (2008) EPO protects critically perfused flap tissue. Ann Surg 248:919–929
Rezaeian F et al (2010) EPO-induced upregulation of endothelial nitric oxide synthase but not vascular endothelial growth factor prevents musculocutaneus tissue from ischemic damage. Lab Invest 90:40
Rockwell WB et al (1989) Keloids and hyperthropic scars: a comprehensive review. Plast Rec Surg 84:827–837
Rolletschek A, Wobus AM (2009) Induced human pluripotent stem cells: promises and open questions. Biol Chem 390:845–849
Schultz C et al (2008) Attenuation of monocyte proinflammatory cytokine responses to Neisseria meningitidis in children by erythropoietin. Clin Exp Immunol 154:187–191
Sorg H et al (2009) Effects of EPO in skin wound healing are dose related. FASEB 23:1–10
Takeuchi O et al (2007) Signalling pathways activated by microorganisms. Curr Opin Cell Biol 19:185–191
Viviani B et al (2005) EPO protects primary hipocamppal neurons increasing the expression of brain-derived neurotrophic factor. J Neurochem 93:412–421
Yazihan N et al (2008) Erythropoietin reduces lipopolysaccharide-induced cell damage and midkine secretion in U937 human histiocytic lymphoma cells. Adv Ther 25:502–514
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Machens, HG., Günter, C.I., Bader, A. (2013). Skin. In: Steinhoff, G. (eds) Regenerative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5690-8_43
Download citation
DOI: https://doi.org/10.1007/978-94-007-5690-8_43
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5689-2
Online ISBN: 978-94-007-5690-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)